Synthesis and evaluation of asymmetric curcuminoid analogs as potential anticancer agents that downregulate NF-κB activation and enhance the sensitivity of gastric cancer cell lines to irinotecan chemotherapy.

[1]  M. Zeng,et al.  Ion channels or aquaporins as novel molecular targets in gastric cancer , 2017, Molecular Cancer.

[2]  S. Zhang,et al.  Curcumin attenuates quinocetone induced apoptosis and inflammation via the opposite modulation of Nrf2/HO-1 and NF-kB pathway in human hepatocyte L02 cells. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[3]  Kerly F. M. Pasqualoto,et al.  Apoptotic effect of eugenol envolves G2/M phase abrogation accompanied by mitochondrial damage and clastogenic effect on cancer cell in vitro. , 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[4]  P. Zou,et al.  Selective killing of gastric cancer cells by a small molecule targeting ROS‐mediated ER stress activation , 2016, Molecular carcinogenesis.

[5]  R. Basha,et al.  Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution. , 2016, The Journal of nutritional biochemistry.

[6]  Durga Prasad Mishra,et al.  Proteasome inhibition mediates p53 reactivation and anti-cancer activity of 6-Gingerol in cervical cancer cells , 2015, Oncotarget.

[7]  M. Campone,et al.  Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis , 2015, Oncotarget.

[8]  D. Mandal,et al.  Induction of Apoptosis by Eugenol and Capsaicin in Human Gastric Cancer AGS Cells--Elucidating the Role of p53. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[9]  S. Choi,et al.  Identification of Sestrin3 Involved in the In vitro Resistance of Colorectal Cancer Cells to Irinotecan , 2015, PloS one.

[10]  M. Del Rio,et al.  FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance , 2015, Molecular Cancer.

[11]  P. Chueh,et al.  Role of ribophorin II in the response to anticancer drugs in gastric cancer cell lines , 2015, Oncology letters.

[12]  G. Haegeman,et al.  Inhibition of the NF-κB Signaling Pathway by a Novel Heterocyclic Curcumin Analogue , 2015, Molecules.

[13]  F. Tsai,et al.  Resistance to irinotecan (CPT-11) activates epidermal growth factor receptor/nuclear factor kappa B and increases cellular metastasis and autophagy in LoVo colon cancer cells. , 2014, Cancer letters.

[14]  Wenyue Wang,et al.  PEITC reverse multi‐drug resistance of human gastric cancer SGC7901/DDP cell line , 2014, Cell biology international.

[15]  G. Wakabayashi,et al.  A Compensatory Role of NF-κB to p53 in Response to 5-FU–Based Chemotherapy for Gastric Cancer Cell Lines , 2014, PloS one.

[16]  J. Snyder,et al.  Liver S9 Fraction-Derived Metabolites of Curcumin Analogue UBS109. , 2014, ACS medicinal chemistry letters.

[17]  Y. Doki,et al.  A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1203 (HERBIS-5). , 2013, Japanese journal of clinical oncology.

[18]  Chi-Tang Ho,et al.  Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells. , 2013, Journal of agricultural and food chemistry.

[19]  J. Snyder,et al.  Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties. , 2013, Journal of medicinal chemistry.

[20]  Chengguang Zhao,et al.  Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs). , 2013, Current pharmaceutical design.

[21]  Aamir Ahmad,et al.  Perspectives on new synthetic curcumin analogs and their potential anticancer properties. , 2013, Current pharmaceutical design.

[22]  A. Mobasheri,et al.  Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-κB and Src Protein Kinase Signaling Pathways , 2013, PloS one.

[23]  L. S. Yazan,et al.  Vanillin differentially affects azoxymethane-injected rat colon carcinogenesis and gene expression. , 2012, Journal of medicinal food.

[24]  Jian Xiao,et al.  A synthetic compound, 1,5‐bis(2‐methoxyphenyl)penta‐ 1,4‐dien‐3‐one (B63), induces apoptosis and activates endoplasmic reticulum stress in non‐small cell lung cancer cells , 2012, International journal of cancer.

[25]  A. Conney,et al.  Synthesis and evaluation of curcumin-related compounds for anticancer activity. , 2012, European journal of medicinal chemistry.

[26]  E. Monti,et al.  Ruthenium-arene complexes of curcumin: X-ray and density functional theory structure, synthesis, and spectroscopic characterization, in vitro antitumor activity, and DNA docking studies of (p-cymene)Ru(curcuminato)chloro. , 2012, Journal of medicinal chemistry.

[27]  H. Tohno,et al.  Sequential irinotecan hydrochloride/S-1 for S-1-resistant inoperable gastric cancer: A feasibility study. , 2012, Oncology letters.

[28]  K. Youssef,et al.  Synthesis of curcumin and ethylcurcumin bioconjugates as potential antitumor agents , 2012, Medicinal Chemistry Research.

[29]  Chi-Tang Ho,et al.  Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. , 2011, Molecular nutrition & food research.

[30]  Timothy C Wang,et al.  Curcumin Induces the Differentiation of Myeloid-Derived Suppressor Cells and Inhibits Their Interaction with Cancer Cells and Related Tumor Growth , 2011, Cancer Prevention Research.

[31]  I. Han,et al.  Capsaicin Induces Apoptosis of Cisplatin-Resistant Stomach Cancer Cells by Causing Degradation of Cisplatin-Inducible Aurora-A Protein , 2011, Nutrition and cancer.

[32]  A. Causse,et al.  Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma. , 2011, Cancer research.

[33]  Jun Du,et al.  Synthesis and identification of new 4-arylidene curcumin analogues as potential anticancer agents targeting nuclear factor-κB signaling pathway. , 2010, Journal of medicinal chemistry.

[34]  J. Kolesar,et al.  Establishment and characterization of irinotecan-resistant human non-small cell lung cancer A549 cells. , 2010, Molecular Medicine Reports.

[35]  Chunfu Wu,et al.  Demethoxycurcumin, a natural derivative of curcumin attenuates LPS-induced pro-inflammatory responses through down-regulation of intracellular ROS-related MAPK/NF-kappaB signaling pathways in N9 microglia induced by lipopolysaccharide. , 2010, International immunopharmacology.

[36]  B. Aggarwal,et al.  Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. , 2010, European journal of pharmacology.

[37]  Li Lin,et al.  New curcumin analogues exhibit enhanced growth‐suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells , 2009, Cancer science.

[38]  Yung-sun Song,et al.  Dimethoxycurcumin, a synthetic curcumin analogue with higher metabolic stability, inhibits NO production, inducible NO synthase expression and NF-kappaB activation in RAW264.7 macrophages activated with LPS. , 2008, Molecular nutrition & food research.

[39]  Yeong Shik Kim,et al.  Comparison of suppressive effects of demethoxycurcumin and bisdemethoxycurcumin on expressions of inflammatory mediators In Vitro and In Vivo , 2008, Archives of pharmacal research.

[40]  B. Aggarwal,et al.  Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. , 2007, Carcinogenesis.

[41]  H. Shibata,et al.  Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer , 2006, Molecular Cancer Therapeutics.

[42]  K. Lee,et al.  Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents. , 2006, Bioorganic & medicinal chemistry.

[43]  W. Wang,et al.  [Reversal of chemoresistance to vincristine in gastric cancer cells by NF-kappaB inhibitor]. , 2005, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[44]  M. Belakavadi,et al.  Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated DNase , 2005, Molecular and Cellular Biochemistry.

[45]  M. Villalona-Calero,et al.  Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.